Display options
Share it on

J Endovasc Ther. 2017 Apr 01;24(2):191-197. doi: 10.1177/1526602816685581. Epub 2017 Jan 06.

Midterm Results of Proximal Aneurysm Sealing With the Ovation Stent-Graft According to On- vs Off-Label Use.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists

Gianmarco de Donato, Francesco Setacci, Luciano Bresadola, Patrizio Castelli, Roberto Chiesa, Nicola Mangialardi, Giovanni Nano, Carlo Setacci,

Affiliations

  1. 1 Division of Vascular Surgery, University of Siena, Italy.
  2. 2 Department of Vascular Surgery, Casa di Cura Giovanni XXIII, Monastier di Treviso, Italy.
  3. 3 Department of Interventional Radiology, Sapienza University of Rome, Italy.
  4. 4 Department of Vascular Surgery, University of Varese, Italy.
  5. 5 Department of Vascular Surgery, Vita-Salute San Raffaele University, Milan, Italy.
  6. 6 Department of Vascular Surgery, Hospital San Filippo Neri, Rome, Italy.
  7. 7 Department of Vascular Surgery, University of Milan, Italy.

PMID: 28058986 DOI: 10.1177/1526602816685581

Abstract

PURPOSE: To compare the use of the Ovation stent-graft according to the ≥7-mm neck length specified by the original instructions for use (IFU) vs those treated off-label (OL) for necks <7 mm long.

METHODS: A multicenter retrospective registry (TriVascular Ovation Italian Study) database of all patients who underwent endovascular aneurysm repair with the Ovation endograft at 13 centers in Italy was interrogated to identify patients with a minimum computed tomography (CT) follow-up of 24 months, retrieving records on 89 patients (mean age 76.4±2.4 years; 84 men) with a mean follow-up of 32 months (range 24-50). Standard CT scans (preoperative, 1-month postoperative, and latest follow-up) were reviewed by an independent core laboratory for morphological changes. For analysis, patients were stratified into 2 groups based on proximal neck length ≥7 mm (IFU group, n=57) or <7 mm (OL group, n=32). Outcome measures included freedom from type Ia endoleak, any device-related reintervention, migration, and neck enlargement (>2 mm).

RESULTS: At 3 years, there was no aneurysm-related death, rupture, stent-graft migration, or neck enlargement. There were no differences in terms of freedom from type Ia endoleak (98.2% IFU vs 96.8% OL, p=0.6; hazard ratio [HR] 0.55, 95% CI 0.02 to 9.71 or freedom from any device-related reintervention (92.8% IFU vs 96.4% OL, p=0.4; HR 2.42, 95% CI 0.34 to 12.99). In the sealing zone, the mean change in diameters was -0.05±0.8 mm in the IFU group and -0.1±0.5 mm in the OL group.

CONCLUSION: Use of the Ovation stent-graft in patients with neck length <7 mm achieved midterm outcomes similar to patients with ≥7-mm-long necks. These midterm data show that the use of the Ovation system for the treatment of infrarenal abdominal aortic aneurysm is not restricted by the conventional measurement of aortic neck length, affirming the recent Food and Drug Administration-approved changes to the IFU.

Keywords: abdominal aortic aneurysm; aneurysm neck; endograft; endoleak; endovascular aneurysm repair; instructions for use; off-label use; proximal sealing; sealing ring; stent-graft

Publication Types